Research Progress of Non-viral Vectors in Tumor Gene Therapy
DOI:
https://doi.org/10.61173/bt1g0359Keywords:
Non-viral gene vectors, Lipid nanoparticles, Polymer nanoparticles, Inorganic nanoparticles, Tumor gene therapyAbstract
Gene therapy introduces genetic material cells to enhance or modify gene function and treat various diseases, including malignant tumors. However, due to poor resistance to degradation in vivo and difficulties in penetrating cell membranes, nucleic acid drugs need the help of vectors to enter target cells. Therefore, the development of safe and high-efficiency nucleic acid vectors is the key to gene therapy. Gene delivery vectors are mainly divided into two categories: viral and non-viral. The latter is concerned because of its low immunogenicity and high gene capacity. This article will summarize the research progress of common non-viral gene vectors in tumor gene therapy.
References
[1] Shirley JL, de Jong YP, Terhorst C, Herzog RW. Immune Responses to Viral Gene Therapy Vectors. Mol Ther. 2020, 28(3), 709-722.
[2] Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021, 6(12), 1078-1094.
[3] Cheng X, Lee RJ. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv Drug Deliv Rev. 2016, 99(Pt A), 129-137.
[4] Patel P, Fetse J, Lin CY, et al. Development of amino acidmodified biodegradable lipid nanoparticles for siRNA delivery. Acta Biomater. 2022, 154, 374-384.
[5] Xu, C., Tian, H. & Chen, X. Recent progress in cationic polymeric gene carriers for cancer therapy. Sci. China Chem. 2017, 60, 319-328.
[6] Rikke V Benjaminsen, Maria A Mattebjerg, Jonas R Henriksen, S Moein Moghimi, Thomas L Andresen. The Possible “Proton Sponge” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH. Molecular Therapy. 2013, 21(1), 149-157.
[7] Diaz IL, Jérôme V, Freitag R, Perez LD. Development of poly(ethyleneimine) grafted amphiphilic copolymers: Evaluation of their cytotoxicity and ability to complex DNA. Journal of Bioactive and Compatible Polymers. 2021, 36(6), 447-463.
[8] Urello MA, Xiang L, Colombo R, et al. Metabolite-Based Modification of Poly(l-lysine) for Improved Gene Delivery. Biomacromolecules. 2020, 21(9), 3596-3607.
[9] Jiang L, Zhou S, Zhang X, et al. Dendrimer-based nanoparticles in cancer chemotherapy and gene therapy. Sci. China Mater. 2018, 61, 1404-1419.
[10] Xu L, Yeudall WA, Yang H. Folic acid-decorated Dean&Francis polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery. Acta Biomater. 2017, 57, 251-261.
[11] Lu Y, Han S, Zheng H, Ma R, Ping Y, Zou J, Tang HX, Zhang Y, Xu X, Li F. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. Int J Nanomedicine. 2018, 13, 5937-5952.
[12] Santos-Carballal B, Fernández Fernández E, Goycoolea FM. Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies. Polymers. 2018, 10(4), 444.
[13] Li Y, Yang J, Xu B, Gao F, Wang W, Liu W. Enhanced Therapeutic siRNA to Tumor Cells by a pH-Sensitive Agmatine- Chitosan Bioconjugate. ACS Appl Mater Interfaces. 2015, 7(15), 8114-8124.
[14] Sardo C, Bassi B, Craparo EF, et al. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells. Int J Pharm. 2017, 519(1-2), 113-124.
[15] Peng LH, Huang YF, Zhang CZ, et al. Integration of antimicrobial peptides with gold nanoparticles as unique nonviral vectors for gene delivery to mesenchymal stem cells with antibacterial activity. Biomaterials. 2016, 103, 137-149.
[16] Wang D, Xu X, Zhang K, et al. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticlespolymerpolyethylenimine to improve oral squamous carcinoma treatment. Int J Nanomedicine. 2017, 13, 187-198.
[17] Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011, 63(1-2), 24-46.
[18] Veiseh O, Kievit FM, Liu V, et al. In vivo safety evaluation of polyarginine coated magnetic nanovectors. Mol Pharm. 2013, 10(11), 4099-4106.
[19] Santhosh PB, Ulrih NP. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. Cancer Lett. 2013, 336(1), 8-17.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
